Anti-IgE Therapy with Omalizumab Decreases Endothelin-1 in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma

Publisher： Karger

E-ISSN： 1423-0356|80|6|534-542

ISSN： 0025-7931

Source： Respiration, Vol.80, Iss.6, 2010-06, pp. : 534-542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RANTES in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma during Omalizumab Therapy

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 1, 2010-07 ,pp. : 25-32

Karger

Access to resources Recommend Favorite

The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden

By Dewilde S.   Turk F.   Tambour M.   Sandström T.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1765-1776

Informa Healthcare

Access to resources Recommend Favorite

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis

By Busse William W.   Massanari Marc   Kianifard Farid   Geba Gregory P.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2379-2386

Informa Healthcare

Access to resources Recommend Favorite

Eotaxin in Exhaled Breath Condensate of Allergic Asthma Patients with Exercise-Induced Bronchoconstriction

By  

Respiration, Vol. 82, Iss. 2, 2011-01 ,pp. : 169-176

Karger

Access to resources Recommend Favorite

RANTES in Exhaled Breath Condensate of Allergic Asthma Patients with Exercise-Induced Bronchoconstriction

By  

Respiration, Vol. 80, Iss. 6, 2009-12 ,pp. : 463-471

Karger

Access to resources Recommend Favorite